Organon Denmark ApS: Financial statements 2023
CVR: 41193093
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Organon Denmark ApS (CVR 41193093) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 63,900,000 and a net result of DKK 2,924,000 compared with DKK 2,139,000 the year before. That is an increase of 3.1% compared with the year before. The profit margin was 4.6%. Equity in the 2023 report amounted to DKK 29,482,000. The solvency ratio was 65.2%. The company had 16 employees in the financial year.
- Revenue
- DKK 63,900,000
- Gross Profit
- DKK 11,902,000
- Profit/Loss
- DKK 2,924,000
- Equity
- DKK 29,482,000
- Total Assets
- DKK 45,249,000
- Employees
- 16
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 63.9M | 11.9M | 2.9M | 29.5M | 16 |
| 2022 | 62M | 11.9M | 2.1M | 26.6M | 16 |
| 2021 | 51M | 8.6M | 857K | 24.4M | 13 |
| 2020 | 49.2M | 4.4M | 1.3M | 22.7M | 5 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Organon Denmark ApS has published its annual report for 2022. Revenue came to DKK 61,971,000, and the net result was DKK 2,139,000.
About Organon Denmark ApS
Organon Denmark ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2020. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named OBS Denmark ApS. The management consists of Anne Bitzer, Karl Johan Sundt and Sofia Raquel Paulos Ferreira Alves da Silva. The company is owned by OBS Human Health Holding B.V.. The company has 6 employees (2026). In 2025, the company reported revenue of DKK 61,554,000 and a net result of DKK 3,139,000 compared with DKK 2,428,000 the year before. Equity in the 2025 report amounted to DKK 31,049,000.